A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain?

Pharmacological Research

Volumn 33, Issue 2, 1996, Pages 73-80

  Pepeu, Giancarlo ^a,b   Pepeu, Ileana Marconcini ^a   Amaducci, Luigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Pharmacology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; GLUCOSE; HISTAMINE; LIPOSOME; PHOSPHATIDYLSERINE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; TYROSINE 3 MONOOXYGENASE;

ACETYLCHOLINE RELEASE; AGING; ALZHEIMER DISEASE; AMNESIA; BRAIN; CALCIUM TRANSPORT; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG ABSORPTION; DRUG MECHANISM; ENZYME ACTIVATION; GLUCOSE BRAIN LEVEL; HISTAMINE RELEASE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0030087583     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0013     Document Type: Article

References (71)

1. 1. Folch J, Schneider HA. An amino acid constituent of ox brain cephalin. J Biol Chem 1941; 137: 51-60.
2. 2. Crook TH, Tinkleberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC. Effects of phosphatidylserine in age-associated memory impairment. Neurology 1991; 41: 644-9.
3. 3. Soares JC, Gershon S. Advances in the pharmacotherapy of Alzheimer's disease. Eur Arch Psych Clin Neurosci 1994; 244: 261-71.
4. 4. Freysz L, Dreyfus C, Vincendon C. Asymmetry of brain microsomal membranes. In: Horrocks L, ed. Phospholipids in the nervous system. v. 1. New York: Raven Press, 1982: 37-47.
5. 5. Gurr MI, James AT. Lipid biochemistry. London: Chapman and Hall, 1971: 125-48.
6. 6. Hermetter A, Paltauf F, Hauser H. Synthesis of diacyl and alkylacyl glycerophosphoserines. Chem Phys Lipids 1982; 50: 35-45.
7. 7. Pepeu G, Casamenti F, Scali C, Jeglinski W. Effect of serine phospholipids on memory and brain cholinergic mechanisms in ageing rats. Neurosci Res Comm. 1993; 13(Suppl 1): S63-6.
8. 8. Bruni A, Mietto L, Secchi FE, et al. Inhibition by cholesterylphosphorylserine of T-cell-mediated immune responses in mice. Int J Immunopharmacol 1995; 17: 517-21.
9. 9. Kaibuchi K, Takay Y, Nishizuka Y. Cooperative roles of various membrane phospholipids in the activation of calcium-activated, phospholipid-dependent protein kinase. J Biol Chem 1981; 256: 7146-9.
10. +)-dependent adenosine triphosphatase by amino acids and phosphatidylserine: chelation of trace metal inhibitors. Arch Biochem Biophys 1973; 154: 314-23.
11. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem J 1984; 220: 301-7.
12. 12. Raese J, Patrick RL, Barchas JD. Phospholipid-induced activation of tyrosine hydroxylase from rat brain striatal synaptosomes. Biochem Pharmacol 1976; 25: 2245-50.
13. 2+ uptake by rat brain synaptosomes. Arch Biochem Biophys 1991; 285: 116-9.
14. 14. Hammond JR, Martin IL. Modulation of [3H]flunitrazepam binding to rat cerebellar benzodiazepine receptors by phosphatidylserine. Eur J Pharmacol 1987; 137: 49-58.
15. 15. Abood LG, Takeda F. Enhancement of stereospecific opiate binding to neurla membranes by phosphatidyl serine. Eur J Pharmacol 1976; 39: 71-7.
16. 16. Foster AC, Fagg GE, Harris EW, Cotman CW. Regulation of glutamate receptors: possible role of phosphatidylserine. Brain Res 1982; 242: 374-7.
17. 17. Goth A, Adams HR, Knoohuizen M. Phosphatidylserine: selective enhancer of histamine release. Science 1971; 173: 1034-5.
18. 18. Mongar YL, Svec P. The effect of phospholipids on anaphylactic histamine release. Br J Pharmacol 1972; 46: 741-52.
19. 19. Foreman JC, Mongar JL. The interaction of calcium and strontium with phosphatidylserine in the anaphylactic secretion of histamine. J Physiol 1973; 230: 493-507.
20. 20. Ponzin D, Mancini D, Toffano C, Bruni A, Doria G. Phosphatidylserine-induced modulation of the immune response in mice: effect of intravenous administration. Immunopharmacol 1989; 18: 167-76.
21. 21. Caselli E, Baricordi OR, Melchiorri L, Bellini F, Ponzin D, Bruni A. Inhibition of DNA synthesis in peripheral blood mononuclear cells treated with phosphatidylserines containing unsaturated acyl chains. Immunopharmacol 1993; 23: 205-13.
22. 22. Monastra G, Bruni A. Decreased serum level of tumor necrosis factor in animals treated with lipopolysaccharide and liposomes containing phosphatidylserine. Lymphokine Cytokine Res 1992; 11: 39-43.
23. 23. Monastra G, Cross AH, Bruni A, Raine CS. Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelination. Neurology 1993; 43: 155-63.
24. 24. Maeda Y, Maeda R, Prineas JW, Ledeen RW. Phosphatidylserine suppresses myelin-induced experimental allergic neuritis (EAN) in Lewis rats. J Neuropathol Exp Neurol 1994; 53: 672-7.
25. 25. Bruni A, Toffano G, Leon A, Barato E. Pharmacological effects of phosphatidylserine liposomes. Nature (London) 1976; 260: 331-3.
26. 26. Bigon B, Boarato E, Bruni A, Leon A, Toffano G. Pharmacological effects of phosphatidylserine liposomes. regulation of glycolysis and energy level in brain. Br J Pharmacol 1979; 66: 167-74.
27. 27. Casamenti F, Mantovani P, Amaducci L, Pepeu G. Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. J Neurochem 1979; 32: 529-33.
28. 28. Mantovani P, Pepeu G, Amaducci L. Investigations into the relationship between phospholipids and brain acetylcholine. In: Porcellati G, Amaducci L, Galli C, eds. Function and metabolism of phospholipids in the central and peripheral nervous system. New York: Plenum Press, 1976: 285-92.
29. 29. Pepeu G, Gori G, Bartolini L. Pharmacologic and therapeutic perspectives on dementia: an experimental approach. In: Amaducci L, Davison AN, Antuono P, eds. Aging of the brain and dementia. New York: Raven Press, 1980: 271-4.
30. 30. Zanotti A, Valzelli L, Toffano G. Reversal of scopolamine-induced amnesia by phosphatidylserine in rats. Psychopharmacol 1986; 90: 274-5.
31. 31. Mantovani P, Aporti F, Bonetti C, Pepeu G. Effects of phosphatidylserine on brain cholinergic mechanisms. In: Horrocks, ed. Phospholipids in the nervous system. v. 1. New York: Raven Press, 1982: 165-72.
32. 32. Drago F, Continella G, Alloro MC, Lo Presti L, Scapagnini U. Behavioral effects of phosphatidylserine after perinatal administration in rats. Int J Devl Neurosci 1984; 2: 347-53.
33. 33. Zanotti A, Aporti F, Toffano G, Valzelli L. Effects of phosphatidylserine on avoidance relearning in rats (preliminary observations). Pharmacol Res Comm 1984; 16: 485-93.
34. 34. Taniguchi M, Kashiwayanagi M, Kurihara K. Enhancement of the turtle olfactory responses to fatty acids by treatment of olfactory epithelium with phosphatidylserine. Brain Res 1994; 647: 10-4.
35. 35. Toffano G, Leon A, Benvegnù D, Boarato E, Azzone GF. Effect of brain cortex phospholipids on catecholamine content of mouse brain. Pharmacol Res Comm 1976; 8: 581-90.
36. 36. Leon A, Benvegnù D, Toffano G, Orlando P, Massari P. Effect of brain cortex phospholipids on adenylate cyclase activity of mouse brain. J Neurochem 1978; 30: 23-6.
37. 37. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-17.
38. 38. Drago F, Canonico PL, Scapagnini U. Behavioral effects of phosphatidylserine in aged rats. Neurobiol Aging 1981; 2: 209-13.
39. 39. Corwin J, Dean RL, Bartus RT, Rotrosen J, Watkins DL. Behavioral effects of phosphatidylserine in the aged Fiscer 344 rat: amelioration of passive avoidance deficits without changes in psychomotor task performance. Neurobiol Aging 1985; 6: 11-15.
40. 40. Aporti F, Borsato R, Calderini G, et al. Age-dependent spontaneous EEG bursts in rat: effects of brain phosphatidylserine. Neurobiol Aging 1986; 7: 115-20.
41. 41. Vannucchi MG, Casamenti F, Pepeu G. Decrease of acetylcholine release from cortical slices in aged rats: investigations into its reversal by phosphatidylserine. J Neurochem 1990; 55: 819-25.
42. 42. Zanotti A, Valzelli L, Toffano G. Chronic phosphatidylserine treatment improves spatial memory and passive avoidance in aged rats. Psychopharmacol 1989; 99: 316-21.
43. 43. Pedata F, Giovannelli L, Spignoli G, Giovannini MG, Pepeu G. Phosphatidylserine increases acetylcholine release from cortical slices in aged rats. Neurobiol Aging 1985; 6: 337-9.
44. 44. Pepeu G, Giovannelli L, Giovannini MG, Pedata F. Effect of phosphatidylserine on cortical acetylcholine release and calcium uptake in adult and ageing rats. In: Horrocks LA, Freysz L, Toffano G, eds. Phospholipid research and the nervous system. Biochemical and molecular pharmacology. Padova: Liviana Press, 1986: 265-71.
45. 45. Casamenti F, Scali C, Pepeu G. Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. Eur J Pharmacol 1991; 194: 11-16.
46. 46. Di Carlo R, Muccioli G, Ghe C, Bellussi G, Ravetti D, Genazzani E. Phosphatidylserine activity on prolactin brain receptors of aged rabbits. Prog Neuro-Psychopharmacol Psychiat 1988; 12: 915-26.
47. 47. Mollace V, Masuda Y, Pelaggi T, Nisticò G. The effects of phosphatidylserine on the decrease cardiovascular response to clonidine microinfused into the nucleus tractus solitarii of old rats. Br J Pharmacol 1990; 100: 547-55.
48. 48. Drago F, Spadaro F, D'Agata V, et al. Protective action of phosphatidylserine on stress-induced behavioral and autonomic changes in aged rats. Neurobiol Aging 1991; 12: 437-40.
49. 49. Nunzi MG, Milan F, Guidolin D, Toffano G. Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine administration. Neurobiol Aging 1987; 8: 501-10.
50. 50. Vannucchi G, Pepeu G. Effect of phosphatidylserine on acetylcholine release and content in cortical slices from ageing rats. Neurobiol Aging 1987; 8: 403-7.
51. 51. Amaducci L, SMID Group. Phosphatidylserine in the treatment of Alzheimer's disease. Results of a multicentric study. Psychopharmacol Bull 1988; 24: 130-4.
52. 52. Crook T, Petrie W, Wells C, Massari Casadei D. Effects of phosphatidylserine in Alzheimer's disease. Psychopharmacol Bull 1992; 28: 61-6.
53. 53. Engel RR, Satzger W, Günther W, et al. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type. Eur Neuropsychopharmacol 1992; 2: 149-55.
54. 54. Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. Dementia 1994; 5: 88-98.
55. 55. Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G et al. Cognitive decline in the elderly: a double-blind. placebo controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33.
56. 56. Palmieri G, Palmieri R, Inzoli MR, et al. Double-blind controlled trial of phosphatidylserine in elderly patients with senile mental deterioration. Clin Trials J 1987; 24: 73-83.
57. 57. Villardita C, Grioloi S, Salmeri G, Nicoletti F, Pennisi G. Multicentre clinical trial of brain phosphatidylserine in elderly patients with intellectual deterioration. Clin Trials J 1987; 24: 84-93.
58. 58. Davis KL, Powchik P. Tacrine. Lancet 1995; 345: 625-30.
59. 59. Canonico PL, Annunziato L, Toffano G, et al. In vivo and in vitro interference of phosphatidylserine liposomes on prolactin secretion in the rat. Neuroendocrinol 1981; 33: 358-62.
60. 60. Monteleone P, May M, Beinat M, Natale M, Kemali D. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamopituitary-adrenal axis in healthy men. Eur J Clin Pharmacol 1992; 41: 385-8.
61. 61. Monteleone P, Beinat L, Tanzillo C, May M, Kemali D. Effects of phosphatidylserine on the neuroendocrine responses to physical stress in humans. Neuroendocrinol 1990; 52: 243-8.
62. 62. Nishijima M, Kuge O, Akamatsu Y. Phosphatidylserine biosynthesis in cultured chinese hamster ovary cells. I Inhibition of de novo phosphatidylserine biosynthesis by exogenous phosphatidylserine and its efficient incorporation. J Biol Chem 1986; 261: 5784-9.
63. 63. Bruni A, Bellini F, Mietto F, Boarato E, Viola G. Phospholipid adsorption and diffusion through membranes. In: Hanin I, Pepeu G, eds. Phospholipids. Biochemical, pharmaceutical, and analytical considerations. New York: Plenum Press, 1990: 59-68.
64. 64. Palatini P, Viola G, Bigon E, Menegus AM, Bruni A. Pharmacokinetic characterization of phosphatidylserine liposomes in the rat. Br J Pharmacol 1991; 102: 345-50.
65. 65. Bruni A, Bellini F, Mietto L, Monastra G, Viola G, Toffano G. Target cells for serine phospholipids. In: Freysz L, Hawthorne JN, Toffano G, eds. Neurochemical aspects of phospholipid metabolism. Padova: Liviana Press/Springer Verlag, 1989: 211-17.
66. 66. Bellini F, Bruni A. Role of a serum phospholipase A1 in the phosphatidylserine-induced T cell inhibition. FEBS Lett 1993; 316: 1-4.
67. 67. Bruni A, Orlando P, Mietto L, Viola G. Phospholipid metabolism in rat intestinal mucosa after oral administration of lysophospholipids. In: Bazan NG, ed. Neurobiology of essential fatty acids. New York: Plenum Press, 1992: 243-9.
68. 68. Calderini G, Bellini F, Bonetti AC, et al. Pharmacological properties of phosphatidylserine in the ageing brain: biochemical aspects and therapeutic potential. In: Horrocks LA, Freysz G, Toffano G, eds. Phospholipid research and the nervous system. Biochemical and molecular pharmacology. Padova: Liviana Press, 1986: 233-41.
69. 69. D'Angelo E, Rossi P, Tanzi F, Taglietti V. Protein kinase C facilitation of acetylcholine release at the rat neuromuscular junction. Eur J Neurosci 1992; 4: 823-31.
70. 70. Fischer W, Wictorin K, Bjorklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neurons atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature (London) 1987; 329: 65-8.
71. 71. Scali C, Casamenti F, Pazzagli M, Bartolini L, Pepeu G. Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. Neurosci Lett 1994; 170: 117-20.